Stay updated on ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Sign up to get notified when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.

Latest updates to the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the history. The site-wide government funding notice was removed from the page.SummaryDifference0.8%

- Check21 days agoChange DetectedA government funding lapse notice was added along with the new revision label Revision: v3.4.1, and the previous revision label Revision: v3.4.0 was removed.SummaryDifference0.8%

- Check28 days agoChange DetectedUpdates on this page are primarily UI and documentation changes, including showing a glossary option, new color-coding cues (green for additions and red for deletions), and updated revision labels (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added to the record history and Revision: v3.3.3 was removed, updating the history for NCT02847624. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded revision entry v3.3.3 to the record history. Removed HHS Vulnerability Disclosure and revision v3.3.2 from the page.SummaryDifference0.2%

- Check71 days agoChange DetectedThe history indicates posted results and associated sections (Results, Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Document Section, Study Design, Study Status), replacing the previous Results Submitted entry.SummaryDifference1%

Stay in the know with updates to ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.